Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ludek Sispera"'
Autor:
Stanislav Mičuda, Martin Hodač, Petr Pařízek, Miloslav Pleskot, Luděk Šišpera, Jaroslav Cerman, Jana Maláková, Jiřina Martínková, Vladimír Pidrman
Publikováno v:
Acta Medica, Vol 43, Iss 3, Pp 95-101 (2000)
The present work was designed to determine whether the individual differences in pharmacokinetics and pharmacodynamics of amiodarone and its N-desethyl metabolite are related to cytochrome CYP3A metabolizer status. Methods: 12 cardiac patients with i
Externí odkaz:
https://doaj.org/article/eb60fc5d97cb471782cf9d559d64cee9
Autor:
Milos Hroch, Martina Rezacova, Ales Bezrouk, Jana Cmielova, Renata Köhlerová, Ludek Sispera, Radim Havelek, Emil Rudolf, Lenka Sucha, Pavel Tomsik
Publikováno v:
Oncology Reports
In recent years, α-tomatine has been studied for its anticancer activity. In the present study, we focused on the cytotoxic effect of α-tomatine in the MCF-7 human breast adenocarcinoma cell line, its mechanism of action, biotransformation and stab
Autor:
Milan Holecek, Ludek Sispera
Publikováno v:
Nutrients
Nutrients, Vol 8, Iss 4, p 206 (2016)
Nutrients, Vol 8, Iss 4, p 206 (2016)
Chronic arginine intake is believed to have favorable effects on the body. However, it might be hypothesized that excessive consumption of an individual amino acid exerts adverse effects on distribution and metabolism of other amino acids. We evaluat
Autor:
Jolana Cermanova, Pavel Tomsik, Halka Lotková, Ludek Sispera, Martina Slanarova, Radek Hyspler, Stanislav Micuda, Eva Brcakova, Leos Fuksa, Gabriela Kolouchova, Petra Hirsova
Publikováno v:
Journal of Gastroenterology and Hepatology. 26:1544-1551
Background and Aim: The administration of pravastatin to patients with cholestatic liver disease has suggested the potential of the drug with regard to reducing raised plasma cholesterol and bile acid levels. Information about the mechanisms associat
Publikováno v:
Journal of Physiology and Biochemistry. 66:311-319
β-Hydroxy-β-methylbutyrate (HMB) is a leucine metabolite that may have a positive effect in protein catabolic conditions. Therefore, we hypothesized that HMB treatment could attenuate the sepsis-induced protein catabolic state. The aims of our stud
Publikováno v:
Amino Acids. 40:575-584
Hyperammonemia is considered to be the main cause of decreased levels of the branched-chain amino acids (BCAA), valine, leucine, and isoleucine, in liver cirrhosis. In this study we investigated whether the decrease in BCAA is caused by the direct ef
Autor:
Tilser I, Miroslav Kovarik, Ludek Sispera, Milan Holecek, Oleg V. Larionov, A. De Meijere, Tomas Muthny
Publikováno v:
ResearcherID
The proteasome inhibitors are used as research tools to study of the ATP-dependent ubiquitin-proteasome system. Some of them are at present undergoing clinical trials to be used as therapeutic agents for cancer or inflammation. These diseases are oft
Publikováno v:
Food and Chemical Toxicology. 47:255-259
Beta-hydroxy-beta-methylbutyrate (HMB) is a leucine metabolite with protein anabolic effect. The aim of the study was to examine the role of exogenous HMB on leucine and protein metabolism in whole body and selected tissues. Rats were administered by
Publikováno v:
International Journal of Experimental Pathology. 89:64-71
The aim of our study was to evaluate the differences in protein and amino acid metabolism after subcutaneous turpentine administration in the soleus muscle (SOL), predominantly composed of red fibres, and the extensor digitorum longus muscle (EDL) co
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 30:467-473
Glutamine and branched-chain amino acids (BCAA; valine, leucine, and isoleucine) are used as nutrition supplements in the treatment of proteocatabolic illness. We hypothesized that simultaneous administration of BCAA and glutamine affects protein met